Development of bivalent rgp120 vaccines to prevent HIV type 1 infection.

Article

Development of bivalent rgp120 vaccines to prevent HIV type 1 infection.

AIDS research and human retroviruses - 1 Oct 1998

Berman P W

Abstract excerpt

A new generation of "bivalent" gp120-based vaccines, effective against subtype B and subtype E viruses, has been developed. Antisera from rabbits and humans immunized with these vaccines are able to neutralize macrophage tropic and T-cell tropic viruses grown in activated peripheral blood mononuc...

Topics

AIDS Vaccines
Amino Acid Sequence
Animals
Genetic Variation
HIV Envelope Protein gp120
HIV Infections
HIV-1
Humans
Macrophages
Molecular Epidemiology
Molecular Sequence Data
Neutralization Tests
Rabbits
T-Lymphocytes

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.